Literature DB >> 19286835

Activation of Rho and Rho-associated kinase by GPR54 and KiSS1 metastasis suppressor gene product induces changes of cell morphology and contributes to apoptosis.

Jean-Marc Navenot1, Nobutaka Fujii, Stephen C Peiper.   

Abstract

The mechanism of action of the metastasis suppressor KiSS1 and its receptor GPR54 is still incompletely characterized. Although the loss of KiSS1 expression by tumor cells has been associated with a metastatic phenotype, the nature of the cellular target of the secreted kisspeptins is unknown. Although an autocrine model of action has been generally assumed, metastasis suppression by KiSS1 has also been shown in cells that do not express GPR54, suggesting a paracrine mechanism in which kisspeptins affect cells in the metastatic niche. Activation of GPR54 was shown to inhibit cell motility and invasion of tumor cells, induce the formation of stress fibers, and reduce the expression of matrix metalloproteinase 9. We showed previously that the activation of GPR54 by kisspeptin-10 suppressed CXCR4-mediated chemotaxis in response to stromal cell-derived factor 1/CXCL12 and abolished the phosphorylation of Akt by CXCR4. We also demonstrated that activation of GPR54 inhibited Akt phosphorylation after the activation of epidermal growth factor receptor and the insulin receptor and triggered apoptosis in epithelial and lymphoid cell lines through a mechanism involving extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase. We show here that the activation of GPR54 induced immediate and profound changes of cell morphology, including cytoplasmic condensation and formation of unpolarized plasma membrane protrusions. These events were dependent on Rho and Rho-Associated Kinase (ROCK) activation. The activation of ROCK also contributed to GPR54-mediated apoptosis in 293 cells, and its effect was additive to and independent of ERK activation. These results suggest that RhoA and ROCK are additional key components of the antimetastatic effect of kisspeptins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19286835     DOI: 10.1124/mol.109.055095

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  20 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin receptor nomenclature, distribution, and function.

Authors:  Helen R Kirby; Janet J Maguire; William H Colledge; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 2.  Kisspeptin signalling in the physiology and pathophysiology of the urogenital system.

Authors:  Fazal Wahab; Bibi Atika; Muhammad Shahab; Rüdiger Behr
Journal:  Nat Rev Urol       Date:  2015-12-01       Impact factor: 14.432

3.  Haploinsufficiency in the prometastasis Kiss1 receptor Gpr54 delays breast tumor initiation, progression, and lung metastasis.

Authors:  Sung-Gook Cho; Ying Wang; Melissa Rodriguez; Kunrong Tan; Wenzheng Zhang; Jian Luo; Dali Li; Mingyao Liu
Journal:  Cancer Res       Date:  2011-08-18       Impact factor: 12.701

4.  KiSS1 mediates platinum sensitivity and metastasis suppression in head and neck squamous cell carcinoma.

Authors:  T Jiffar; T Yilmaz; J Lee; E Hanna; A El-Naggar; D Yu; J N Myers; M E Kupferman
Journal:  Oncogene       Date:  2011-03-07       Impact factor: 9.867

5.  Value of CagA, HER2, ALDH1, and KiSS-1 in predicting metastasis and prognosis for gastric adenocarcinoma.

Authors:  Guoyu Lu; Xiaolin Wang; Yichao Wang; Zenong Cheng; Lei Zhou
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

Review 6.  Role of the tumor microenvironment in regulating the anti-metastatic effect of KISS1.

Authors:  Sitaram Harihar; Srijit Ray; Samyukta Narayanan; Anirudh Santhoshkumar; Thuc Ly; Danny R Welch
Journal:  Clin Exp Metastasis       Date:  2020-02-22       Impact factor: 5.150

7.  The transcription factor GCF2 is an upstream repressor of the small GTPAse RhoA, regulating membrane protein trafficking, sensitivity to doxorubicin, and resistance to cisplatin.

Authors:  Ding-Wu Shen; Lynn M Pouliot; Jean-Pierre Gillet; Wenting Ma; Alfred C Johnson; Matthew D Hall; Michael M Gottesman
Journal:  Mol Pharm       Date:  2012-05-17       Impact factor: 4.939

8.  The KISS1 metastasis suppressor appears to reverse the Warburg effect by shifting from glycolysis to mitochondrial beta-oxidation.

Authors:  Sharon J Manley; Wen Liu; Danny R Welch
Journal:  J Mol Med (Berl)       Date:  2017-06-08       Impact factor: 4.599

9.  Inotropic action of the puberty hormone kisspeptin in rat, mouse and human: cardiovascular distribution and characteristics of the kisspeptin receptor.

Authors:  Janet J Maguire; Helen R Kirby; Emma J Mead; Rhoda E Kuc; Xavier d'Anglemont de Tassigny; William H Colledge; Anthony P Davenport
Journal:  PLoS One       Date:  2011-11-22       Impact factor: 3.240

10.  The effects of kisspeptin-10 on migration and proliferation of endothelial cell.

Authors:  Fatemeh Golzar; Shaghayegh Haghjooy Javanmard
Journal:  Adv Biomed Res       Date:  2015-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.